The human genome and sport, including epigenetics and athleticogenomics: A brief look at a rapidly changing field

Journal of Sports Sciences

Volumn 26, Issue 11, 2008, Pages 1127-1133

  Sharp, N C Craig ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Athleticogenomics; Epigenetics; Gene doping; Genome; Sport

Indexed keywords

ADA PROTEIN; APOLIPOPROTEIN; COMPLEMENTARY RNA; DOUBLE STRANDED RNA; ERYTHROPOIETIN RECEPTOR; GENE PRODUCT; MYOSTATIN; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; SOMATOMEDIN C; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALZHEIMER DISEASE; ATHLETE; AUTOIMMUNITY; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; COMPETITION; CORONARY ARTERY DISEASE; DNA FINGERPRINTING; DNA SEQUENCE; DOPING; DRUG EFFICACY; DRUG SAFETY; ENDURANCE; EPIGENETICS; FITNESS; GENE ACTIVITY; GENE CONTROL; GENE DELETION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE FUNCTION; GENE INSERTION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMICS; HETEROZYGOSITY; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; HUMAN GENOME; INHERITANCE; MARFAN SYNDROME; MULTIGENE FAMILY; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; MUTATIONAL ANALYSIS; NONHUMAN; NONVIRAL GENE THERAPY; ONCOVIRINAE; PARKINSON DISEASE; PHENOTYPE; PHYSICAL PERFORMANCE; PROTEOMICS; REVIEW; RNA INTERFERENCE; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; TRAINING; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION;

DOPING IN SPORTS; EPIGENESIS, GENETIC; GENE THERAPY; GENOME, HUMAN; HUMANS; SIGNAL TRANSDUCTION; SPORTS;

EID: 51649106174     PISSN: 02640414     EISSN: 1466447X     Source Type: Journal    
DOI: 10.1080/02640410801912117     Document Type: Review

References (61)

1. Abbott, A. (2006) Youthful duo snag a swift Nobel for RNA control of genes. Nature, 433, p. 488.
2. American Physiological Society's on-line journal. Physiological Genomics
3. Baumgartner, I., Pieczek, A. and Manor, O. (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation, 97, pp. 1114-1123.
4. Booth, F. W. and Neufer, P. D. (2005) Exercise controls gene expression. American Scientist, 93, pp. 28-35.
5. Bouchard, C., Malina, R. M. and Perusse, L. (1999) The genetics of fitness and physical performance, Human Kinetics, Champaign, IL
6. Brenner, S. and Roberts, R. (2007) Genome sequencing. Nature, 446, p. 725.
7. Budgett, R., Newsholme, E. A., Lehman, M., Sharp, N. C. C., Jones, D. Peto, R. et al. (2000) Redefining the overtraining syndrome as the unexplained underperformance syndrome. British Journal of Sports Medicine, 34, pp. 67-68.
8. Check, E. (2007) Sequencing revolution ushers in new era. Nature, 448, pp. 9-11.
9. Cox, J. C., Reimann, F., Nicholas, A. K., Thornton, G., Roberts, E. Springell, K. et al. (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature, 444, pp. 894-898.
10. Culver, K., Anderson, F. and Blaese, R. (1991) Lymphocyte gene therapy. Human Gene Therapy, 2, pp. 107-109.
11. de la Chapelle, A., Sistonen, P., Lehvaslaiho, H., Ikkala, E. and Juvonen, E. (1993) Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet, 341, pp. 82-84.
12. de la Chapelle, A., Traskelin, A. -L. and Juvonen, E. (1993) Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proceedings of the National Academy of Sciences USA, 90, pp. 4495-4499.
13. Doliny, D. C., Weidman, J. R., Waterland, R. A. and Jirtle, R. L. (2006) Maternal genisten alters coat colour and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environment and Health Perspectectives, 114, pp. 567-572.
14. Dunlap, K. A., Palmarini, M., Vareia, M., Burghardt, R. C., Farmer, J. L. and Spencer, T. E. (2006) Endogeneous retrovirus regulates peri-implantation, placental growth and differentiation. Proceedings of the National Academy of Sciences, 103:39, pp. 14390-14395.
15. Ecclestone, A., DeWitt, N., Gunter, C., Marte, B. and Nath, D. (2007) Epigenetics; Nature Insight. Nature, 447, pp. 395-440.
16. Gee, H. (2004) Jacob's Ladder: The history of the human genome, 4th Estate, London
17. Goldspink, G. (1992) The brains behind the brawn. New Scientist, 135:1832, pp. 28-33.
18. Hamer, C. and Copeland, J. (1998) Living with our genes, Doubleday, New York
19. Jordan, B. D. (2000) Chronic traumatic brain injury associated with boxing. Seminars in Neurology, 20, pp. 179-185.
20. Jordan, B. D., Relkin, N. R. and Ravdin, L. D. (1997) Apolipoprotein E4 associated with chronic traumatic brain injury in boxing. Journal of the American Medical Association, 278, pp. 136-140.
21. Kaushik, N., Fear, D., Richards, S. C. M., McDermott, C. R., Nuwaysir, E. F. Kellam, P. et al. (2005) Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. Journal of Clinical Pathology, 58, pp. 826-832.
22. Kim, T. H., Barerra, L. O. and Zheng, M. (2005) A high-resolution map of active promoters in the human genome. Nature, 436, pp. 876-878.
23. Knight, J. (2003) No dope. Nature, 426, pp. 114-115.
24. Kodadek, T., Xiao, X., Yu, P., Lim, H. -Y. and Sikder, D. (2007) Turning up genes. Reported in "Research Highlights". Nature, 446, p. 472.
25. Lee, S. -J. and McPheron, A. C. (2001) Regulation of myostatin activity and muscle growth. Proceedings of the National Academy of Sciences USA, 98, pp. 9306-9311.
26. Lyon, M. (2007) How X-chromosome inactivation was discovered. Biologist, 54:2, pp. 94-97.
27. MacArthur, D. G. and North, K. N. (2004) A gene for speed? The evolution and function of alpha-actinin-3. Bioessays, 26, pp. 786-795.
28. MacArthur, D. G. and North, K. N. (2007) Genes and human elite performance. East African running: Towards a cross-disciplinary perspective, pp. 217-233. Routledge, Abingdon, UK
29. Margulies, M., Egholm, M. and Altman, W. E. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature, 437, pp. 376-380.
30. McPheron, A. C., Lawler, A. M. and Lee, S. -J. (1997) Regulation of skeletal muscle mass in mice by a new TGF-B superfamily member. Nature, 387, pp. 83-90.
31. Miah, A. (2004) Genetically modified athletes: Biomedical ethics, gene doping and sport, Routledge, Abingdon, UK
32. Montgomery, H. E., Marshall, R., Hemingway, H., Myerson, S., Clarkson, P. Dollery, C. et al. (1998) Human gene for physical performance. Nature, 393, pp. 221-222.
33. Mosher, D. S., Quignon, P., Bustamante, C. D., Sutter, N. B., Mellersh, C. S. Parker, H. G. et al. (2007) A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genetics, 3:5, p. e79.
34. Nakamura, T., Lozano, P. R., Ikeda, Y., Hinek, A. Minamisawa, S. et al. (2002) Fibululin-5/DANCE is essential for elastogenesis in vivo. Nature, 415, pp. 171-175.
35. Noakes, T. D., St. Clair, G. A. and Lambert, E. V. (2004) From catastrophe to complexity: A novel model of integrative central neural regulation of effort and fatigue during exercise in humans. British Journal of Sports Medicine, 38, pp. 511-514.
36. Pando, O. J. and Verstrepan, K. J. (2007) Epigenetic switches. Cell, 128, pp. 655-668.
37. Parisotto, R. (2006) Blood sports: The inside dope on drugs in sport, Hardie Grant Books, Prahran, VIC
38. Rankinen, T., Bray, M. S., Hagberg, J. M., Perusse, L., Roth, S. M. Wolfarth, B. et al. (2006) The human gene map for performance and health-related fitness phenotypes: The 2005 update. Medicine and Science in Sports and Exercise, 38, pp. 1863-1888.
39. Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H. Andrews, T. D. et al. (2006) Global variation in copy number in the human genome. Nature, 444, pp. 428-429.
40. Riggs, A. D. (1996) Epigenetics: Mechanism of gene regulation, Cold Spring Harbor Laboratory Press, New York
41. Rogers, J. and Venter, J. C. (2005) Massively parallel sequencing. Nature, 437, pp. 326-327.
42. Savulescu, J. (2005) Genetic testing for APOE4 and boxing. Genetic technology and sport: Ethical questions, pp. 136-146. Routledge, Abingdon, UK
43. Schjerling, P. (2005) The basics of gene doping. Genetic technology and sport: Ethical questions, pp. 19-31. Routledge, Abingdon, UK
44. Shadan, S. (2007) Run, whippet, run. MSTN gene and racing performance. Nature, 447, p. 275.
45. Sharp, N. C. C. (1999) Drugs wipe out a sporting chance. Nature, 398, p. 675.
46. Sharp, N. C. C. (2004) Doping-a misuse of science. Physiology News, 57, pp. 15-16.
47. Sharp, N. C. C. (2006) Athleticogenomics. Peak Performance, 230, pp. 8-11.
48. Sharp, N. C. C. (2007) Introduction. East African running: Towards a cross-disciplinary perspective, pp. 1-7. Routledge, Abingdon, UK
49. Slot, O. (2006) Raising the bar in the cheating stakes. The Times
50. Sweeney, H. L. (2004) Gene doping. Scientific American, 291, pp. 36-43.
51. Tamburrini, C. and Tannsjo, T. (2005) Genetic technology and sport: Ethical questions, Routledge, Abingdon, UK
52. Tamburrini, C. and Tannsjo, T. (2005) Genetic design of a new Amazon. Genetic technology and sport: Ethical questions, pp. 181-198. Routledge, Abingdon, UK
53. Waddington, C. H. (1942) The epigenome. Endeavour, 1, pp. 18-20.
54. Wade, N. (2001) Life script: How the human genome discoveries will transform medicine, Simon & Schuster, New York
55. Wagner, R. and Sun, L. (1998) Functional genomics: Double-stranded RNA poses puzzle. Nature, 391, pp. 744-745.
56. Wang, J. (2007) Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature, 446, pp. 881-884.
57. Waterland, R. A. and Jirtle, R. L. (2003) Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Molecular and Cell Biology, 23, pp. 5293-5300.
58. Waterland, R. A., Travisano, M. and Tahiliani, K. G. (2007) Diet-induced hypermethylation at agouti viable yellow is not inherited transgenerationally through the female. FASEB Journal, 21, pp. 3380-3385.
59. Weiss, A., McDonough, D., Wertman, B., Acakpo-Satchivi, L., Montgomery, K. Kucherlapati, R. et al. (1999) Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. Proceedings of the National Academy of Sciences USA, 96, pp. 2958-2963.
60. Yang, N., MacArthur, D. G., Gulbin, J. P., Hahn, A. G., Beggs, A. H. Easteal, S. et al. (2003) ACTN3 genotype is associated with human elite athletic performance. American Journal of Human Genetics, 73, pp. 627-631.
61. Zamore, P. D. (2007) Genomic defence with a slice of Pi: RNA silencing. Nature, 446, pp. 864-865.